Revolutionizing Healthcare: Redi Health's Major Funding, AI advancements by NuraLogix and Neurable, and Novo Nordisk's Bold Acquisition

AI in Life Sciences

Content provided by Stan Berteloot. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stan Berteloot or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

4M ago 4:16

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 08, 2024 07:55 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

On today's episode of AI in Life Sciences, we cover Redi Health's fruitful Series B funding round, and its plans to revolutionize healthcare using tech-integrated solutions. We delve into the groundbreaking use of digital twins powered by AI in cost reduction, advanced disease detection, personalized medicine, and optimization of operations in the healthcare sector. We also introduce NuraLogix's Anura MagicMirror, an innovative smart device that uses facial blood flow data for vital sign calculations and disease risk assessments. Next, we discuss the Children's Hospital Los Angeles's ambient AI assistant, Nabla Copilot, and its role in reducing practitioner stress and improving patient care. We explore the partnership between Neurable and Healthspan Digital, broadening access to the ground-breaking brain-computer interface tech. And finally, we unveil Novo Nordisk's acquisition of Cardior Pharmaceuticals, expanding its cardiometabolic medicine pipeline.

17 episodes

#Science #Biology #News #Tech News #Stan Berteloot #Technology #Pharma